ALT in the 13F filings
Altimmune Inc · CUSIP 02155H200
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 17 Feb 2026
- up to 45 days after the quarter end
- Managers listing it
- 1
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 1 listed it in both
- Shares listed
- 27,600
- combined, among listed positions
- Reported value
- $104k
- combined, at the quarter end
Among the 95 comparable managers: 0 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was 0.
Managers listing ALT in Q3 2025
1 of 1 holder
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Farallon Capital Management LLC | 27,600 | $104k | under 0.1% | Held | 0 | 17 Feb 2026 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
No increase among listed positions.
Reductions
No reduction among listed positions.
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 1 | $8.4m | n.a. | n.a. |
| Q3 2020 | 1 | $952k | n.a. | n.a. |
| Q2 2021 | 1 | $15m | n.a. | n.a. |
| Q3 2021 | 1 | $3.9m | n.a. | n.a. |
| Q4 2021 | 2 | $6.8m | n.a. | n.a. |
| Q1 2022 | 2 | $5.9m | n.a. | n.a. |
| Q2 2022 | 2 | $8.0m | n.a. | n.a. |
| Q3 2022 | 4 | $89m | n.a. | n.a. |
| Q4 2022 | 5 | $133m | n.a. | n.a. |
| Q4 2023 | 1 | $382k | 1 | 0 |
| Q1 2024 | 2 | $7.0m | 2 | 0 |
| Q2 2024 | 1 | $184k | 0 | 1 |
| Q3 2024 | 1 | $169k | 0 | 0 |
| Q4 2024 | 1 | $199k | 0 | 0 |
| Q1 2025 | 1 | $138k | 0 | 0 |
| Q2 2025 | 1 | $107k | 0 | 0 |
| Q3 2025 | 1 | $104k | 0 | 0 |
| Q4 2025 | 1 | $100k | 14 | 9 |
| Q1 2026 | 1 | $85k | 10 | 12 |
| Q2 2026 | 1 | $20m | 20 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ALT and LLY →ALT and JNJ →ALT and VRTX →Choose a stock to compare with ALT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ALT, latest filings →Back to the 13F Explorer →